EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 23 filers reported holding EVOKE PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $31,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 175,000 | $448,000 | 0.59% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $1,280,000 | 0.22% |
PRECEPT MANAGEMENT LLC | 95,000 | $243,000 | 0.15% |
Family Management Corp | 10,425 | $27,000 | 0.02% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 400,000 | $1,024,000 | 0.01% |
Acrospire Investment Management LLC | 2,489 | $6,000 | 0.01% |
A.R.T. Advisors, LLC | 15,413 | $39,000 | 0.00% |
NORTHERN TRUST CORP | 29,214 | $75,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 23,048 | $59,000 | 0.00% |
DEUTSCHE BANK AG\ | 200 | $0 | 0.00% |